Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002477179 | SCV002781004 | uncertain significance | Tumoral calcinosis, hyperphosphatemic, familial, 3 | 2022-03-29 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000054738 | SCV003295533 | uncertain significance | not provided | 2022-12-24 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KL protein function. ClinVar contains an entry for this variant (Variation ID: 64551). This variant has not been reported in the literature in individuals affected with KL-related conditions. This variant is present in population databases (rs387907444, gnomAD 0.009%). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 166 of the KL protein (p.Asn166Ser). |
Martin Pollak Laboratory, |
RCV000054738 | SCV000077428 | unknown | not provided | no assertion criteria provided | not provided | Converted during submission to Uncertain significance. |